Journal article
Bioprocess intensification: Cases that (don't) work
University of Limerick1
Department of Biotechnology and Biomedicine, Technical University of Denmark2
Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark3
Section for Synthetic Biology, Department of Biotechnology and Biomedicine, Technical University of Denmark4
BioBased Innovation5
Development of affordable and low carbon biobased manufacturing depends critically on strategies that reduce cost and emission profiles. This paper indicates that efforts around the reduction of capital costs by intensification of process equipment need to be carefully weighed against the inherently fast increasing financial and climate costs of driving forces used for the intensification.
The fundamental relation between capital expenditures (CAPEX) and operational expenditures (OPEX) of intensified and non-intensified biobased processes and their financial and climatic impacts are emphasized and provisionally explored for a few industrial processes. General learnings flag the importance in particular of OPEX minimisation for sustainable bio-economic development.
| Language: | English |
|---|---|
| Year: | 2021 |
| Pages: | 108-115 |
| ISSN: | 18764347 and 18716784 |
| Types: | Journal article |
| DOI: | 10.1016/j.nbt.2020.11.007 |
| ORCIDs: | Mussatto, Solange I. and 0000-0002-8198-2143 |
Bioprocess intensification Integrated biobased manufacturing SDG 13 - Climate Action SDG 8 - Decent Work and Economic Growth Techno-economic assessment Thermodynamic analysis
Biotechnology Costs and Cost Analysis Techno-Economic assessment
